¶ Garbarino Voted For Massive Cuts To Medicare And Voted Against Allowing Medicare To Negotiate The Prices Of Prescription Drugs
¶ 2025: Garbarino Voted For House Republicans’ Reconciliation Bill, Which Would Trigger Nearly $500 billion In Medicare Cuts
July 2025: Garbarino Voted For The Senate FY 2025 Budget Reconciliation Bill That Extended $4 Trillion In Expiring Tax Cuts, Added New Tax Breaks, Appropriated $448 Billion In Defense, Border, And Immigration Enforcement Funding, Increased The SALT Deduction To $40,000, And Cut Medicaid And Other Social Programs To Offset The Costs. In July 2025, Garbarino voted for, according to Congressional Quarterly, the “motion to concur in the Senate amendment to the bill that would permanently extend nearly $4 trillion in expiring individual and business tax cuts, create several new tax breaks and fund border and immigration enforcement and air traffic control upgrades. It would cut Medicaid and other safety net programs to partly offset the cost. Among other provisions, it would raise the statutory debt ceiling by $5 trillion and appropriate more than $448 billion in mandatory funding for Trump administration priorities and other needs, including $153 billion for defense, $89 billion for immigration enforcement, and $89.5 billion for border control and security. It also would increase the state and local tax deduction cap to $40,000 annually for five years for households making up to $500,000 a year until 2030, when it would permanently revert to $10,000.” The House passed the bill by a vote of 218 to 214. [House Vote 190, 7/3/25; Congressional Quarterly, 7/3/25; Congressional Actions, H.R. 1]
- Congressional Budget Office Estimated That The House Republican Reconciliation Bill Would Trigger Nearly $500 Billion In Cuts To Medicare. According to a letter the Congressional Budget Office sent to Rep. Brendan Boyle, "Today the Congressional Budget Office transmitted an estimate of the budgetary effects of the 2025 reconciliation bill, as ordered reported by the House Committee on the Budget on May 18, 2025. 1 CBO has not yet completed estimates of the effects of interactions among the titles of the legislation. This letter responds to your questions concerning the sequestration (the cancellation of budgetary resources) in accordance with the Statutory Pay‑As‑You‑Go Act of 2010 (S-PAYGO) that would occur if an enacted bill raised deficits by $2.3 trillion over 10 years. Under S-PAYGO, the Office of Management and Budget (OMB) is required to maintain 5- and 10-year scorecards that it updates with the estimated cumulative changes in revenues and outlays generated by newly enacted legislation. […] The 4 percent maximum reduction in Medicare spending would apply to sequestration orders for years after 2026. If OMB ordered a sequestration of $230 billion for each year through 2034, the ordered reductions in Medicare spending would increase to about $75 billion in 2034 and would total roughly $490 billion over the 2027–2034 period." [Letter to Rep. Brendan Boyle – Congressional Budget Office, 5/20/25]
¶ May 2025: Garbarino Missed The Vote On The House Republicans’ Reconciliation Bill, Which Would Trigger Nearly $500 billion In Medicare Cuts
May 2025: Garbarino Missed The Vote On The FY 2025 Budget Reconciliation Bill That Included $3.8 Trillion In Tax Cuts Offset By $1.5 Trillion In Spending Reductions To Programs Like Medicaid And The Supplemental Nutrition Assistance Program. In May 2025, Garbarino was absent on the vote that, according to Congressional Quarterly, “the bill that would provide for approximately $3.8 trillion in net tax cuts and $321 billion in military, border enforcement and judiciary spending, offset by $1.5 trillion in spending reductions, as instructed in the fiscal 2025 budget resolution. It would raise the statutory debt limit by $4 trillion and provide for increased spending on defense and border security, spending cuts on social safety net programs, such as Medicaid and the Supplemental Nutrition Assistance Program. It also includes a mix of tax breaks for businesses and individuals; tax increases on universities and foundations; and a phase-down of clean energy tax credits. […] It would reduce federal spending on the Supplemental Nutrition Assistance Program by requiring states to shoulder more of the cost, expand work requirements for SNAP, extend programs authorized under the 2018 farm bill, and prohibit the U.S. Department of Agriculture from increasing the cost of the Thrifty Food Program. As amended, it would cap state and local tax deductions at $40,000 for households with incomes below $500,000.” The House passed the bill by a vote of 215 to 214. [House Vote 145, 5/22/25; Congressional Quarterly, 5/22/25; Congressional Actions, H.R. 1]
- HEADLINE: "Trump And GOP’s Tax Bill Would Force Cuts To Medicare, CBO Says" [Washington Post, 5/21/25]
- Congressional Budget Office Estimated That The House Republican Reconciliation Bill Would Trigger Nearly $500 Billion In Cuts To Medicare. According to a letter the Congressional Budget Office sent to Rep. Brendan Boyle, "Today the Congressional Budget Office transmitted an estimate of the budgetary effects of the 2025 reconciliation bill, as ordered reported by the House Committee on the Budget on May 18, 2025. 1 CBO has not yet completed estimates of the effects of interactions among the titles of the legislation. This letter responds to your questions concerning the sequestration (the cancellation of budgetary resources) in accordance with the Statutory Pay‑As‑You‑Go Act of 2010 (S-PAYGO) that would occur if an enacted bill raised deficits by $2.3 trillion over 10 years. Under S-PAYGO, the Office of Management and Budget (OMB) is required to maintain 5- and 10-year scorecards that it updates with the estimated cumulative changes in revenues and outlays generated by newly enacted legislation. […] The 4 percent maximum reduction in Medicare spending would apply to sequestration orders for years after 2026. If OMB ordered a sequestration of $230 billion for each year through 2034, the ordered reductions in Medicare spending would increase to about $75 billion in 2034 and would total roughly $490 billion over the 2027–2034 period." [Letter to Rep. Brendan Boyle – Congressional Budget Office, 5/20/25]
¶ Garbarino Said He Was “Moments Away” From Voting “Yes” On The Republican Budget Bill, But He Fell Asleep
Garbarino Said He Was Moments Away From Voting For The Republican Budget Bill, But He Fell Asleep. According to USA Today, "The House of Representatives on Thursday passed a sweeping bill packed with President Donald Trump’s legislative priorities in a huge win for House Speaker Mike Johnson, R-Louisiana. The bill passed by a vote of 215-214. But there were a few Republican lawmakers who didn’t cast yes votes - including one who fell asleep. Johnson said that New York Republican Rep. Andrew Garbarino ‘fell asleep in the back’ after an all-night session with others discussing the bill and inadvertently missed the vote. […] Garbarino said in a statement to USA TODAY that he was ‘moments away from the House floor, to vote ‘yes,’ when the vote was closed.’" [USA Today, 5/22/25]
- 5/22/25: Garbarino Said He Looked Forward To Voting Yes On The Big Beautiful Bill When It Came Back From The Senate. According to Politico, “GOP Reps. Andrew Garbarino of New York and David Schweikert of Arizona were both recorded as not voting on the Republican domestic policy megabill that passed the House early Thursday morning. […] Garbarino said he was ‘proud of the work we accomplished to deliver huge results for Long Island’ and that he ‘look[s] forward to voting ‘yes’ when it comes back to the House floor from the Senate.’” [Politico, 5/22/25]
¶ Garbarino Repeatedly Voted Against Allowing Medicare To Negotiate The Prices Of Prescription Drugs
2022: Garbarino Voted Against The Inflation Reduction Act, Which Required The Department Of Health And Human Services To Negotiate Fair Prices With Drug Manufacturers For Certain Medicare-Eligible, Brand-Name Drugs Without Generic Competition. In August 2022, according to Congressional Quarterly, Garbarino voted against concurring in the Senate amendment to the Inflation Reduction Act of 2022, which would “require the Health and Human Services Department to negotiate a ‘maximum fair price’ with drug manufacturers for certain Medicare-eligible, brand-name drugs that do not have generic competition.” The vote was on a motion to concur. The House concurred with the Senate by a vote 220-207, thus the bill was sent to President Biden for final signage. President Biden signed the bill and it ultimately became law. [House Vote 420, 8/12/22; Congressional Quarterly, 8/12/22; Congressional Actions, H.R. 5376]
2021: Garbarino Voted Against Directing The Department Of Health And Human Services To Negotiate Lower Prescription Drug Prices For Insulin And Certain Medicare-Eligible Drugs That Lack Generic Competition. In November 2021, Garbarino voted against the Build Back Better act which would, according to Congressional Quarterly, “require the Health and Human Services Department to negotiate a ‘maximum fair price’ for insulin and select Medicare-eligible, brand-name drugs that do not have generic competition.” The vote was on passage. The House passed the bill by a vote of 220-213. [House Vote 385, 11/19/21; Congressional Quarterly, 11/19/21; Congressional Actions, H.R. 5376]
- The Bill Allowed HHS To Negotiate The Prices Of Prescription Drugs Covered By Medicare And Penalize Companies That Don’t Comply. According to Vox, “Under current law, the Health and Human Services secretary is barred from engaging in negotiations for prescription drugs covered by Medicare […] The final bill enables the HHS secretary to negotiate the prices of as many as 250 drugs annually. Additionally, it would penalize companies that do not negotiate with HHS with a fine starting at 65 percent of a drug’s gross sales from the prior year. For every quarter that the company does not engage, the penalty goes up by 10 percentage points, until it hits 95 percent of a drug’s gross sales.” [Vox, 12/12/19]
¶ The Inflation Reduction Act Would Lower Prescription Drug Costs For More Than 650,000 New Yorkers
The Inflation Reduction Act Would Lower Prescription Drug Costs For More Than 650,000 New Yorkers Who Take Drugs That Were Selected For Price Negotiation. According to the U.S. Department of Health and Human Services,
[U.S. Department of Health and Human Services, Lowering Prescription Drug Costs for New York, Viewed 2/19/26]